765 related articles for article (PubMed ID: 7501353)
1. The effect of combined antenatal vitamin K and phenobarbital therapy on umbilical blood coagulation studies in infants less than 34 weeks' gestation.
Thorp JA; Caspers DR; Cohen GR; Zucker ML; Strope BD; McKenzie DR
Obstet Gynecol; 1995 Dec; 86(6):982-9. PubMed ID: 7501353
[TBL] [Abstract][Full Text] [Related]
2. Maternal antenatal administration of vitamin K1 results in increasing the activities of vitamin K-dependent coagulation factors in umbilical blood and in decreasing the incidence rate of periventricular-intraventricular hemorrhage in premature infants.
Liu J; Wang Q; Gao F; He JW; Zhao JH
J Perinat Med; 2006; 34(2):173-6. PubMed ID: 16519625
[TBL] [Abstract][Full Text] [Related]
3. Combined antenatal vitamin K and phenobarbital therapy for preventing intracranial hemorrhage in newborns less than 34 weeks' gestation.
Thorp JA; Ferrette-Smith D; Gaston LA; Johnson J; Yeast JD; Meyer B
Obstet Gynecol; 1995 Jul; 86(1):1-8. PubMed ID: 7784000
[TBL] [Abstract][Full Text] [Related]
4. Maternal administration of vitamin K does not improve the coagulation profile of preterm infants.
Kazzi NJ; Ilagan NB; Liang KC; Kazzi GM; Poland RL; Grietsell LA; Fujii Y; Brans YW
Pediatrics; 1989 Dec; 84(6):1045-50. PubMed ID: 2587133
[TBL] [Abstract][Full Text] [Related]
5. Maternally administered antenatal vitamin K1: effect on neonatal prothrombin activity, partial thromboplastin time, and intraventricular hemorrhage.
Pomerance JJ; Teal JG; Gogolok JF; Brown S; Stewart ME
Obstet Gynecol; 1987 Aug; 70(2):235-41. PubMed ID: 3601288
[TBL] [Abstract][Full Text] [Related]
6. Antepartum vitamin K and phenobarbital for preventing intraventricular hemorrhage in the premature newborn: a randomized, double-blind, placebo-controlled trial.
Thorp JA; Parriott J; Ferrette-Smith D; Meyer BA; Cohen GR; Johnson J
Obstet Gynecol; 1994 Jan; 83(1):70-6. PubMed ID: 8272312
[TBL] [Abstract][Full Text] [Related]
7. [Coagulation tests in newborn infants and their dynamics in relation to vitamin K prophylaxis].
Vakrilova L; Mladenova A; Slŭncheva B
Akush Ginekol (Sofiia); 1993; 32(3):20-3. PubMed ID: 8037311
[TBL] [Abstract][Full Text] [Related]
8. Coagulation studies in very low-birthweight infants.
Seguin JH; Topper WH
Am J Perinatol; 1994 Jan; 11(1):27-9. PubMed ID: 8155205
[TBL] [Abstract][Full Text] [Related]
9. The combined antenatal corticosteroids and vitamin K therapy for preventing periventricular-intraventricular hemorrhage in premature newborns less than 35 weeks gestation.
Liu J; Wang Q; Zhao JH; Chen YH; Qin GL
J Trop Pediatr; 2006 Oct; 52(5):355-9. PubMed ID: 16751657
[TBL] [Abstract][Full Text] [Related]
10. Antenatal vitamin K therapy of the low-birth-weight infant.
Dickson RC; Stubbs TM; Lazarchick J
Am J Obstet Gynecol; 1994 Jan; 170(1 Pt 1):85-9. PubMed ID: 8296850
[TBL] [Abstract][Full Text] [Related]
11. [The effect of plasma fraction I-O, ACC 76, PAMBA and haemarctin on the blood coagulation system of premature newborn infants].
Rogner G
Z Kinderheilkd; 1967; 101(3):230-41. PubMed ID: 5626847
[No Abstract] [Full Text] [Related]
12. Maternal-fetal transport of vitamin K1 and its effects on coagulation in premature infants.
Yang YM; Simon N; Maertens P; Brigham S; Liu P
J Pediatr; 1989 Dec; 115(6):1009-13. PubMed ID: 2585215
[TBL] [Abstract][Full Text] [Related]
13. Effects of preeclampsia on maternal and cord blood clotting activity.
Lox CD; Word RA; Corrigan JJ
Am J Perinatol; 1985 Oct; 2(4):279-82. PubMed ID: 4052178
[TBL] [Abstract][Full Text] [Related]
14. [Level of vitamin K-dependent coagulation factors in premature infants and the influence of maternal antenatal administration of vitamin K1 on their activity].
Liu J; Wang Q; Chen YH; Qin GL; Zhao JH; Zhu LC
Zhonghua Er Ke Za Zhi; 2005 Dec; 43(12):908-10. PubMed ID: 16412352
[TBL] [Abstract][Full Text] [Related]
15. [Effects of the administration of vitamin K on the activity of Factor II, VII and X in healthy newborns].
Arteaga-Vizcaíno M; Torres-Espina M; Redondo L; Soto-Torres L; Diez-Ewald M; Vizcaíno-Salazar G; Torres-Guerra E; Fernández N
Invest Clin; 1995 Jun; 36(2):83-93. PubMed ID: 7548303
[TBL] [Abstract][Full Text] [Related]
16. Congenital bleeding disorders of the vitamin K-dependent clotting factors.
Girolami A; Scandellari R; Scapin M; Vettore S
Vitam Horm; 2008; 78():281-374. PubMed ID: 18374200
[TBL] [Abstract][Full Text] [Related]
17. Vitamin K effect in low birth weight infants.
Ogata T; Motohara K; Endo F; Kondo Y; Ikeda T; Kudo Y; Iribe K; Matsuda I
Pediatrics; 1988 Mar; 81(3):423-7. PubMed ID: 3344186
[TBL] [Abstract][Full Text] [Related]
18. Laboratory coagulation parameters in extremely premature infants born earlier than 27 gestational weeks upon admission to a neonatal intensive care unit.
Neary E; Okafor I; Al-Awaysheh F; Kirkham C; Sheehan K; Mooney C; Foran A; Corcoran JD; Ni Ainle F; Cotter M; McCallion N
Neonatology; 2013; 104(3):222-7. PubMed ID: 24030102
[TBL] [Abstract][Full Text] [Related]
19. [Effect of oral and intramuscular vitamin K on the factors II, VII, IX, X, and PIVKA II in the infant newborn under 60 days of age].
Arteaga-Vizcaíno M; Espinoza Holguín M; Torres Guerra E; Diez-Ewald M; Quintero J; Vizcaíno G; Estévez J; Fernández N
Rev Med Chil; 2001 Oct; 129(10):1121-9. PubMed ID: 11775338
[TBL] [Abstract][Full Text] [Related]
20. Coagulation profile in healthy Nigerian neonates.
Okunade MA; Essien EM
Afr J Med Med Sci; 1998; 27(1-2):71-2. PubMed ID: 10456134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
